Lee's Pharmaceutical Holdings Limited
Other OTCTotal Valuation
Lee's Pharmaceutical Holdings Limited carries a market capitalization of 112.06M, placing it among publicly traded companies globally. Its enterprise value stands at 70.88T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 112.06M |
| Enterprise Value | 70.88T |
Share Statistics
Lee's Pharmaceutical Holdings Limited currently has 588.84M shares outstanding.
| Shares Outstanding | 588.84M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Lee's Pharmaceutical Holdings Limited trades at a trailing price-to-earnings ratio of 1.38M. The price-to-sales ratio is 57,475.80, and the price-to-book ratio stands at 19,834.26.
| PE Ratio | 1.38M |
| PS Ratio | 57,475.80 |
| PB Ratio | 19,834.26 |
| P/TBV Ratio | 86,950.75 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Lee's Pharmaceutical Holdings Limited trades at an EV/EBITDA multiple of 926,133.34 and an EV/FCF ratio of 15.85M. The EV/Sales ratio of 57,475.71 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 926,133.34 provides insight into valuation relative to core operating earnings.
| EV / Sales | 57,475.71 |
| EV / EBITDA | 926,133.34 |
| EV / EBIT | 926,133.34 |
| EV / FCF | 15.85M |
Financial Position
Lee's Pharmaceutical Holdings Limited maintains a current ratio of 1.00, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 8.87, indicating elevated leverage, while an interest coverage ratio of 11.56 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.00 |
| Quick Ratio | 0.29 |
| Debt / Equity | 8.87 |
| Debt / EBITDA | 2.14 |
| Interest Coverage | 11.56 |
Financial Efficiency
Lee's Pharmaceutical Holdings Limited posts a return on equity of 2.85 and a return on invested capital of 2.21.
| Return on Equity (ROE) | 2.85 |
| Return on Assets (ROA) | 1.60 |
| Return on Invested Capital (ROIC) | 2.21 |
| Return on Capital Employed (ROCE) | 3.16 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.59 |
Taxes
Over the trailing twelve months, Lee's Pharmaceutical Holdings Limited has paid 22.03M in income taxes, reflecting an effective tax rate of 32.46.
| Income Tax | 22.03M |
| Effective Tax Rate | 32.46 |
Stock Price Statistics
Lee's Pharmaceutical Holdings Limited's stock has gained approximately 1.11583% over the past 52 weeks. The 50-day moving average sits at 0.19, while the 200-day moving average is 0.19.
| Beta (5Y) | N/A |
| 52-Week Price Change | 1.11583% |
| 50-Day Moving Average | 0.19 |
| 200-Day Moving Average | 0.19 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Lee's Pharmaceutical Holdings Limited generated 1.23B in revenue and converted that into 51.28M in net income, yielding earnings per share of 0.08. EBITDA reached 76.53M, while operating income came in at 76.53M.
| Revenue | 1.23B |
| Gross Profit | 770.76M |
| Operating Income | 76.53M |
| Pretax Income | 67.86M |
| Net Income | 51.28M |
| EBITDA | 76.53M |
| EBIT | 76.53M |
| Earnings Per Share (EPS) | 0.08 |
Balance Sheet
Lee's Pharmaceutical Holdings Limited holds 189.30M in cash and equivalents against 163.49M in total debt, resulting in a net debt position of -35.21M. Total book value stands at 3.57B, with working capital of 1.53M providing operational flexibility.
| Cash & Cash Equivalents | 189.30M |
| Total Debt | 163.49M |
| Net Debt | -35.21M |
| Equity (Book Value) | 3.57B |
| Book Value Per Share | 6.07 |
| Working Capital | 1.53M |
Margins
Lee's Pharmaceutical Holdings Limited operates with a gross margin of 62.50, reflecting its pricing power and cost economics. The operating margin of 6.21 and net profit margin of 4.16 provide insight into operational efficiency.
| Gross Margin | 62.50 |
| Operating Margin | 6.21 |
| Pretax Margin | 5.50 |
| Profit Margin | 4.16 |
| EBITDA Margin | 6.21 |
Scores
Lee's Pharmaceutical Holdings Limited posts an Altman Z-Score of 45,267.67, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 45,267.67 |